All Phenotypes Pik3cb<tm1.1Ehi> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi	B6.129P2-Pik3cb^tm1.1Ehi	MGI:4358062
hm2	Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi	involves: 129P2/OlaHsd	MGI:4358067
hm3	Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi	involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J	MGI:4358061
hm4	Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi	involves: 129/Sv * 129P2/OlaHsd * C57BL/6J	MGI:6856717
cx5	Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi Tg(MMTVneu)202Mul/0	involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J * FVB/N	MGI:4358063

Allelic Composition	Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi
Genetic Background	B6.129P2-Pik3cb^tm1.1Ehi

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pik3cb^tm1.1Ehi mutation (0 available); any Pik3cb mutation (151 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

homeostasis/metabolism

increased insulin secretion ( J:152332 )

• after 6 months

increased circulating glucose level ( J:152332 )

• after 6 months

impaired gluconeogenesis ( J:152332 )

• insulin-mediated gluconeogenesis is impaired

decreased liver glycogen level ( J:152332 )

• decreased glycogen level in the liver at 24 weeks

insulin resistance ( J:152332 )

• mild after 6 months

liver/biliary system

decreased liver glycogen level ( J:152332 )

• decreased glycogen level in the liver at 24 weeks

endocrine/exocrine glands

pancreatic islet hyperplasia ( J:152332 )

• after 6 months

increased insulin secretion ( J:152332 )

• after 6 months

Allelic Composition	Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi
Genetic Background	involves: 129P2/OlaHsd

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pik3cb^tm1.1Ehi mutation (0 available); any Pik3cb mutation (151 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

hematopoietic system

abnormal platelet physiology ( J:152267 )

• platelet adhesion and spreading is reduced compared to in wild-type cells

• platelet spreading on fibrinogen is almost completely abolished unlike for wild-type cells

decreased platelet aggregation ( J:152267 )

• adenosine 5'-diphosphate (ADP)-induced platelet aggregation is impaired unlike in similarly treated wild-type cells

• when treated with U46619, platelet aggregation is impaired 30% compared to in similarly treated wild-type cells

• convulxin-induced aggregation is almost completely abolished compared to in similarly treated wild-type cells

homeostasis/metabolism

abnormal platelet physiology ( J:152267 )

• platelet adhesion and spreading is reduced compared to in wild-type cells

• platelet spreading on fibrinogen is almost completely abolished unlike for wild-type cells

decreased platelet aggregation ( J:152267 )

• adenosine 5'-diphosphate (ADP)-induced platelet aggregation is impaired unlike in similarly treated wild-type cells

• when treated with U46619, platelet aggregation is impaired 30% compared to in similarly treated wild-type cells

• convulxin-induced aggregation is almost completely abolished compared to in similarly treated wild-type cells

Allelic Composition	Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi
Genetic Background	involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pik3cb^tm1.1Ehi mutation (0 available); any Pik3cb mutation (151 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

lethality throughout fetal growth and development, incomplete penetrance ( J:152332 )

• 50% fewer than expected mice are born

embryonic lethality during organogenesis, incomplete penetrance ( J:152332 )

• 30% of mice are moribund at E13.5

growth/size/body

decreased embryo size ( J:152332 )

• in 30% of mice at E13.5

decreased birth body size ( J:152332 )

postnatal growth retardation ( J:152332 )

• 20% until 24 weeks of age

homeostasis/metabolism

decreased circulating cholesterol level ( J:152332 )

decreased circulating triglyceride level ( J:152332 )

cellular

decreased fibroblast proliferation ( J:152332 )

• mouse embryonic fibroblasts with low expression of the allele exhibit decreased proliferation compared with wild-type cells

• however, MEFs expressing high levels of the allele exhibit normal proliferation

embryo

decreased embryo size ( J:152332 )

• in 30% of mice at E13.5

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

reproductive system

reproductive system phenotype ( J:165087 , J:165087 )

N	• unlike males, females are fully fertile (J:165087)
N	• adult males show a normal number of Sertoli cells in the seminiferous tubules with no apparent defect in their position, cell volume or morphology (J:165087)

abnormal spermatogonia morphology ( J:165087 )

• in adult testes, the number of undifferentiated spermatogonial cells is significantly reduced, as determined by TRA98 staining

• however, the number of TRA98-positive cells at P5 is normal, indicating normal primordial germ cell (PGC) migration during embryogenesis

decreased male germ cell number ( J:165087 )

• adult mice show a significant loss of TRA98-positive spermatogenic cells with no detectable changes in the numbers of PLZF-positive spermatogonial stem cells (SSCs)

• adult testes show loss of c-Kit-positive type B spermatogonia and spermatocytes

increased testis apoptosis ( J:165087 )

• at P10, TUNEL staining showed a 2.5-fold increase in apoptosis within the seminiferous tubules, whereas only a few TUNEL-positive cells are detected in wild-type testes

abnormal seminiferous tubule morphology ( J:165087 )

• a paucity of cells is observed within seminiferous tubules

abnormal testis interstitial tissue morphology ( J:165087 )

• focal hyperplasia of the testis interstitial components is observed

• however, Leydig cell number is normal

small testis ( J:165087 )

• males exhibit severe testicular hypotrophy at 24 weeks of age

decreased testis weight ( J:165087 )

• average testis weight is significantly decreased at 24 weeks of age

abnormal spermatogenesis ( J:165087 )

• spermatogenesis is severely impaired

azoospermia ( J:165087 )

• decrease in number of spermatozoa ranges from oligozoospermia to azoospermia

oligozoospermia ( J:165087 )

• number of spermatozoa obtained from the deferens ducts is significantly decreased

• decrease in number of spermatozoa ranges from oligozoospermia to azoospermia

abnormal spermatogonia proliferation ( J:165087 )

• number of actively proliferating PCNA and cyclin D1-positive cells is strikingly reduced at P10 and at 8 weeks of age

reduced male fertility ( J:165087 )

• when males are mated with receptive females for 6 months, the number of litters produced per month is significantly lower than that for wild-type males

cellular

abnormal spermatogonia morphology ( J:165087 )

• in adult testes, the number of undifferentiated spermatogonial cells is significantly reduced, as determined by TRA98 staining

• however, the number of TRA98-positive cells at P5 is normal, indicating normal primordial germ cell (PGC) migration during embryogenesis

decreased male germ cell number ( J:165087 )

• adult mice show a significant loss of TRA98-positive spermatogenic cells with no detectable changes in the numbers of PLZF-positive spermatogonial stem cells (SSCs)

• adult testes show loss of c-Kit-positive type B spermatogonia and spermatocytes

azoospermia ( J:165087 )

• decrease in number of spermatozoa ranges from oligozoospermia to azoospermia

oligozoospermia ( J:165087 )

• number of spermatozoa obtained from the deferens ducts is significantly decreased

• decrease in number of spermatozoa ranges from oligozoospermia to azoospermia

increased testis apoptosis ( J:165087 )

• at P10, TUNEL staining showed a 2.5-fold increase in apoptosis within the seminiferous tubules, whereas only a few TUNEL-positive cells are detected in wild-type testes

abnormal spermatogonia proliferation ( J:165087 )

• number of actively proliferating PCNA and cyclin D1-positive cells is strikingly reduced at P10 and at 8 weeks of age

homeostasis/metabolism

increased circulating follicle stimulating hormone level ( J:165087 )

• adult males exhibit significantly higher plasma FSH levels than wild-type controls

• in contrast, plasma testosterone levels are normal

endocrine/exocrine glands

increased testis apoptosis ( J:165087 )

• at P10, TUNEL staining showed a 2.5-fold increase in apoptosis within the seminiferous tubules, whereas only a few TUNEL-positive cells are detected in wild-type testes

abnormal seminiferous tubule morphology ( J:165087 )

• a paucity of cells is observed within seminiferous tubules

abnormal testis interstitial tissue morphology ( J:165087 )

• focal hyperplasia of the testis interstitial components is observed

• however, Leydig cell number is normal

small testis ( J:165087 )

• males exhibit severe testicular hypotrophy at 24 weeks of age

decreased testis weight ( J:165087 )

• average testis weight is significantly decreased at 24 weeks of age

Allelic Composition	Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi Tg(MMTVneu)202Mul/0
Genetic Background	involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pik3cb^tm1.1Ehi mutation (0 available); any Pik3cb mutation (151 available)
Tg(MMTVneu)202Mul mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

decreased mammary gland tumor incidence ( J:152332 )

• development of first mammary tumor is delayed, number of tumors produced is decreased, and tumors growth is slower compared to in mice expression Tg(MMTVneu)202Mul alone

decreased tumor growth/size ( J:152332 )

• tumor growth is reduced compared to in mice expression Tg(MMTVneu)202Mul alone

integument

decreased mammary gland tumor incidence ( J:152332 )

• development of first mammary tumor is delayed, number of tumors produced is decreased, and tumors growth is slower compared to in mice expression Tg(MMTVneu)202Mul alone

endocrine/exocrine glands

decreased mammary gland tumor incidence ( J:152332 )

• development of first mammary tumor is delayed, number of tumors produced is decreased, and tumors growth is slower compared to in mice expression Tg(MMTVneu)202Mul alone

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/30/2024 MGI 6.23